Ovid Therapeutics
OVID
OVID
60 hedge funds and large institutions have $71.7M invested in Ovid Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
50% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 22
Holders
60
Holding in Top 10
1
Calls
$17K
Puts
–
Top Buyers
| 1 | +$4.3M | |
| 2 | +$2.47M | |
| 3 | +$309K | |
| 4 |
E
Ergoteles
New York
|
+$141K |
| 5 |
Jane Street
New York
|
+$83.8K |
Top Sellers
| 1 | -$2.83M | |
| 2 | -$809K | |
| 3 | -$344K | |
| 4 |
Bank of New York Mellon
New York
|
-$261K |
| 5 |
DA
DCF Advisers
Greenwich,
Connecticut
|
-$172K |